Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $14.48 million. The enterprise value is $2.67 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 2.54 million shares outstanding. The number of shares has increased by 143.83% in one year.
| Current Share Class | 2.54M |
| Shares Outstanding | 2.54M |
| Shares Change (YoY) | +143.83% |
| Shares Change (QoQ) | +35.32% |
| Owned by Insiders (%) | 4.05% |
| Owned by Institutions (%) | 8.13% |
| Float | 2.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.21 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.92 |
| Quick Ratio | 5.55 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -156.90% and return on invested capital (ROIC) is -99.49%.
| Return on Equity (ROE) | -156.90% |
| Return on Assets (ROA) | -79.25% |
| Return on Invested Capital (ROIC) | -99.49% |
| Return on Capital Employed (ROCE) | -100.14% |
| Weighted Average Cost of Capital (WACC) | 27.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.66M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.93% in the last 52 weeks. The beta is 4.23, so INTS's price volatility has been higher than the market average.
| Beta (5Y) | 4.23 |
| 52-Week Price Change | -88.93% |
| 50-Day Moving Average | 7.53 |
| 200-Day Moving Average | 8.42 |
| Relative Strength Index (RSI) | 36.36 |
| Average Volume (20 Days) | 26,371 |
Short Selling Information
The latest short interest is 52,723, so 2.08% of the outstanding shares have been sold short.
| Short Interest | 52,723 |
| Short Previous Month | 71,994 |
| Short % of Shares Out | 2.08% |
| Short % of Float | 2.24% |
| Short Ratio (days to cover) | 0.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.97M |
| Pretax Income | -11.61M |
| Net Income | -11.61M |
| EBITDA | n/a |
| EBIT | -11.97M |
| Earnings Per Share (EPS) | -$8.56 |
Full Income Statement Balance Sheet
The company has $11.92 million in cash and $110,000 in debt, with a net cash position of $11.81 million or $4.65 per share.
| Cash & Cash Equivalents | 11.92M |
| Total Debt | 110,000 |
| Net Cash | 11.81M |
| Net Cash Per Share | $4.65 |
| Equity (Book Value) | 11.88M |
| Book Value Per Share | 4.70 |
| Working Capital | 10.56M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -9.23M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -143.83% |
| Shareholder Yield | -143.83% |
| Earnings Yield | -80.16% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for INTS is $56.25, which is 886.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.25 |
| Price Target Difference | 886.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 19, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Feb 19, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |